- (S)-citalopram S(+)-citalopram BDBM50302225 CITALOPRAM ESCITALOPRAM OXALATE escitalopram (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile CHEMBL1508
- CHEMBL1200322 BDBM50323776 ESCITALOPRAM OXALATE (S)-citalopram oxalate LU-26-054-0
- 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile CHEMBL549 Escitalopram [3H]Citalopram CITALOPRAM CITALOPRAM HYDROBROMIDE [3H]Lexapro [3H]Escitalopram BDBM25870 [3H]Cytalopram
- Nisa, MU; Munawar, MA; Iqbal, A; Ahmed, A; Ashraf, M; Gardener, QA; Khan, MA Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors. Eur J Med Chem 138: 396-406 (2017)
- Mehr-un-Nisa, na; Munawar, MA; Chattha, FA; Kousar, S; Munir, J; Ismail, T; Ashraf, M; Khan, MA Synthesis of novel triazoles and a tetrazole of escitalopram as cholinesterase inhibitors. Bioorg Med Chem 23: 6014-24 (2015)
- Owens, JM; Knight, DL; Nemeroff, CB [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine]. Encephale 28: 350-5 (2002)